Advance care planning in patients with advanced cancer: A 6-country, cluster-randomised clinical trial
- Korfage, I.J. (Ida)
- Carreras, G.
- Arnfeldt Christensen, C.M.
- Billekens, P
- Bramley, L.
- Briggs, L.
- Bulli, F
- Caswell, G
- Červ, B.
- Delden, J.J.M.
- Deliens, L. (Luc)
- Dunleavy, L
- Eecloo, K.
- Gorini, G
- Groenvold, M. (M.)
- Hammes, B.
- Ingravallo, F
- Jabbarian, L.J. (Lea)
- Kars, MC
- Kodba-Čeh, H.
- Lunder, U
- Miccinesi, G. (Guido)
- Mimić, A.
- Ozbič, P.
- Seymour, J. (Jane)
- Simonič, A.
- Johnsen, AT
- Toccafondi, A.
- Payne, SA
- Polinder, S. (Suzanne)
- Pollock, K
- Preston, NJ
- Verkissen, MN
- Wilcock, A
- Zwakman, M
- van derHeide, A.
- Rietjens, J.A.C. (Judith)
Publication date
November 2020
DOI Publisher
Public Library of Science (PLoS)Abstract
Background Advance care planning (ACP) supports individuals to define, discuss, and record goals and preferences for future medical treatment and care. Despite being internationally recommended, randomised clinical trials of ACP in patients with advanced cancer are scarce. Methods and findings To test the implementation of ACP in patients with advanced cancer, we conducted a cluster-randomised trial in 23 hospitals across Belgium, Denmark, Italy, Netherlands, Slovenia, and United Kingdom in 2015–2018. Patients with advanced lung (stage III/IV) or colorectal (stage IV) cancer, WHO performance status 0–3, and at least 3 months li
Add to ORKG